Protein design startup Outpace lands $144M to test treatments that target solid tumors Outpace Bio, a Seattle startup using artificial intelligence to design proteins that are incorporated into cancer therapies targeting solid tumors,… Read More
Tech Moves: Meta exec joins AI startup, Lyell Immunopharma hires new CEO; and more — Claudiu Bulai is now chief innovation officer at Bellevue, Wash.-based startup Quantarium. Bulai previously spent five years at Meta,… Read More
Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of… Read More
Researchers create synthetic proteins that use logic to choose which cells to kill The age of molecular-scale computing is entering a new era, thanks to the development of a system that uses synthetic… Read More
